immunogenicity
Showing 8976 - 8992 of 8,992
HIV Trial in St Louis, Rochester (rgp120/HIV-1MN Monovalent Octameric V3 Peptide Vaccine)
Completed
- HIV Infections
- rgp120/HIV-1MN Monovalent Octameric V3 Peptide Vaccine
-
St Louis, Missouri
- +1 more
Jun 23, 2005
Prevention of Anthrax Infection Trial in United States (rPA102 Vaccine)
Completed
- Prevention of Anthrax Infection
- rPA102 Vaccine
-
Atlanta, Georgia
- +3 more
Jun 23, 2005
HIV Trial in San Francisco (HIV-1 Peptide Vaccine, Microparticulate Monovalent, rgp120/HIV-1MN Monovalent Octameric V3 Peptide
Completed
- HIV Infections
- HIV-1 Peptide Vaccine, Microparticulate Monovalent
- rgp120/HIV-1MN Monovalent Octameric V3 Peptide Vaccine
-
San Francisco, CaliforniaUniv of California at San Francisco Gen Hosp
Jun 23, 2005
HIV Trial in Baltimore, Rochester (HIV-1 Peptide Vaccine, Microparticulate Monovalent)
Completed
- HIV Infections
- HIV-1 Peptide Vaccine, Microparticulate Monovalent
-
Baltimore, Maryland
- +1 more
Jun 23, 2005
HIV Trial in Baltimore, Nashville, Seattle (P3C541b Lipopeptide)
Completed
- HIV Infections
- P3C541b Lipopeptide
-
Baltimore, Maryland
- +2 more
Jun 23, 2005
HIV Trial in Birmingham, Rochester, Seattle (HIV-1 Peptide Vaccine, Microparticulate Monovalent, HIV-1 Peptide Immunogen,
Completed
- HIV Infections
- HIV-1 Peptide Vaccine, Microparticulate Monovalent
- HIV-1 Peptide Immunogen, Multivalent
-
Birmingham, Alabama
- +2 more
Jun 23, 2005
Level of Immunity Against Poliovirus Infection Trial (Inactivated Polio Vaccine given at an accelerated schedule)
Completed
- Level of Immunity Against Poliovirus Infection
- Inactivated Polio Vaccine given at an accelerated schedule
- (no location specified)
Nov 29, 2005
HIV Trial in St Louis, Rochester, Nashville (rgp120/HIV-1IIIB, rgp120/HIV-1MN)
Completed
- HIV Infections
- rgp120/HIV-1IIIB
- rgp120/HIV-1MN
-
St Louis, Missouri
- +2 more
Jun 23, 2005
Impact of HIV on Measles and Measles Immunisation
Completed
- HIV Infection
- +2 more
- standard-titer measles vaccine
-
Lusaka, ZambiaChawama Clinic
Oct 28, 2005
Anthrax Trial in United States (rPA102)
Completed
- Anthrax
- rPA102
-
Torrance, California
- +11 more
Jan 10, 2006
HIV Trial in United States (MN rgp120/HIV-1 and GNE8 rgp120/HIV-1, MN rgp120/HIV-1 and A244 rgp120/HIV-1, Aluminum hydroxide)
Completed
- HIV Infections
- MN rgp120/HIV-1 and GNE8 rgp120/HIV-1
- +2 more
-
Denver, Colorado
- +3 more
Jun 23, 2005
Cytokines in Guillain Barré Syndrome: Correlation With Clinical
Unknown status
- Guillain Barré Syndrome
-
Taipei, TaiwanDepartment of Anatomy and Cell Biology, National Taiwan Universi
Nov 29, 2005
HIV, HIV Seronegativity Trial in Omaha (HIV p24/MF59 Vaccine)
Completed
- HIV Infections
- HIV Seronegativity
- HIV p24/MF59 Vaccine
-
Omaha, NebraskaCreighton Univ Med Ctr / Ped Infect Disease Div
Jun 23, 2005
Multiple Sclerosis Trial (mAb M-T412)
Completed
- Multiple Sclerosis
- monoclonal antibody M-T412
- (no location specified)
Jun 23, 2005
Adenocarcinoma Trial in Bronx (ING-1(heMAb))
Completed
- Adenocarcinoma
-
Bronx, New YorkJack D. Weiler Hospital of the Albert Einstein College of Medici
Jun 23, 2005
Pertussis Trial (diphtheria-tetanus-pertussis vaccine containing whole-cell pertussis, diphtheria-tetanus vaccine)
Completed
- Pertussis
- diphtheria-tetanus-pertussis vaccine containing whole-cell pertussis
- diphtheria-tetanus vaccine
- (no location specified)
Jun 23, 2005